NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...
The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.
Lassa fever remains a major health challenge in Nigeria, killing 100 people in early 2025. What’s going wrong?
The Nigeria Centre for Disease Control and Prevention (NCDC) has recorded 28 new confirmed cases and three deaths from Lassa ...
Renowned Nigerian physician, Dr. Tochi Okwor, said that the 2018 Lassa fever outbreak exposed critical gaps in the nation’s infection ...
The Benue State Government has confirmed one death from Lassa fever and two isolated cases of the viral disease in the state.
The Benue State Government has confirmed one death from Lassa fever and two isolated cases of the viral disease in the state.
An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.
A (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.
The Nigeria Centre for Disease Control and Prevention (NCDC) has reported a decline in new confirmed Lassa fever cases across ...
A probiotic mixture containing three specific probiotic bacterial strains reduces fever duration by 2 days in children with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback